RBC Life Sciences, Inc. (RBCL)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Jul 8, 2025
RBC Life Sciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | 2005 - 2009 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '15 Sep 30, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 | Dec '11 Dec 31, 2011 | Dec '10 Dec 31, 2010 | 2005 - 2009 |
Cash & Equivalents | 2.09 | 1.92 | 3.75 | 3.9 | 3.86 | 4.22 | Upgrade |
Cash & Short-Term Investments | 2.09 | 1.92 | 3.75 | 3.9 | 3.86 | 4.22 | Upgrade |
Cash Growth | 49.57% | -48.70% | -3.86% | 0.97% | -8.57% | 6.25% | Upgrade |
Accounts Receivable | 1.17 | 1.29 | 0.89 | 0.88 | 0.59 | 0.49 | Upgrade |
Other Receivables | - | - | 0.02 | - | 0 | 0 | Upgrade |
Receivables | 1.17 | 1.29 | 0.91 | 0.88 | 0.59 | 0.49 | Upgrade |
Inventory | 4.99 | 4.8 | 5.14 | 5.08 | 6.45 | 5.34 | Upgrade |
Prepaid Expenses | 0.32 | 0.24 | 0.17 | 0.22 | 0.17 | 0.16 | Upgrade |
Other Current Assets | 0.23 | 0.22 | 0.62 | 0.61 | 0.45 | 0.64 | Upgrade |
Total Current Assets | 9.21 | 8.85 | 11.02 | 11.15 | 11.98 | 11.26 | Upgrade |
Property, Plant & Equipment | 1.34 | 4.68 | 4.17 | 4.49 | 4.49 | 4.64 | Upgrade |
Goodwill | 2.16 | 2.22 | 2.26 | 2.3 | 2.29 | 2.3 | Upgrade |
Other Intangible Assets | 0.03 | 0.04 | 0.04 | 0.04 | 0.05 | 0.06 | Upgrade |
Long-Term Accounts Receivable | - | 0 | - | - | - | - | Upgrade |
Other Long-Term Assets | 0.1 | 0.2 | 0.05 | 0.03 | 0.02 | 0.1 | Upgrade |
Total Assets | 12.83 | 16 | 17.53 | 18.01 | 18.83 | 18.34 | Upgrade |
Accounts Payable | 1.14 | 2.31 | 1.61 | 1.5 | 2.17 | 2.11 | Upgrade |
Accrued Expenses | 1.21 | 1.42 | 1.16 | 1.11 | 1.07 | 0.98 | Upgrade |
Current Portion of Long-Term Debt | - | 0.23 | 0.21 | 0.2 | 0.18 | 0.17 | Upgrade |
Current Unearned Revenue | 1.91 | 2.15 | 3.68 | 3.23 | 2.99 | 2.49 | Upgrade |
Total Current Liabilities | 4.26 | 6.11 | 6.66 | 6.03 | 6.41 | 5.75 | Upgrade |
Long-Term Debt | - | 0.91 | 1.14 | 1.35 | 1.55 | 1.73 | Upgrade |
Long-Term Deferred Tax Liabilities | 0.53 | 0.56 | 0.73 | 1.12 | 1.01 | 0.99 | Upgrade |
Total Liabilities | 4.79 | 7.57 | 8.52 | 8.5 | 8.96 | 8.47 | Upgrade |
Common Stock | 0 | 0 | 0 | 0 | 0.02 | 0.02 | Upgrade |
Additional Paid-In Capital | 13.71 | 13.71 | 13.71 | 13.71 | 13.65 | 13.61 | Upgrade |
Retained Earnings | -5.88 | -5.42 | -4.81 | -4.31 | -3.95 | -3.88 | Upgrade |
Comprehensive Income & Other | 0.2 | 0.13 | 0.11 | 0.12 | 0.14 | 0.13 | Upgrade |
Shareholders' Equity | 8.04 | 8.43 | 9.01 | 9.52 | 9.86 | 9.88 | Upgrade |
Total Liabilities & Equity | 12.83 | 16 | 17.53 | 18.01 | 18.83 | 18.34 | Upgrade |
Total Debt | - | 1.14 | 1.35 | 1.55 | 1.73 | 1.9 | Upgrade |
Net Cash (Debt) | 2.09 | 0.79 | 2.4 | 2.35 | 2.13 | 2.32 | Upgrade |
Net Cash Growth | 908.84% | -67.25% | 1.97% | 10.30% | -8.31% | 21.04% | Upgrade |
Net Cash Per Share | 0.95 | 0.35 | 1.08 | 1.06 | 0.96 | 1.04 | Upgrade |
Filing Date Shares Outstanding | 2.21 | 2.21 | 2.21 | 2.22 | 2.22 | 2.22 | Upgrade |
Total Common Shares Outstanding | 2.21 | 2.21 | 2.21 | 2.22 | 2.22 | 2.22 | Upgrade |
Working Capital | 4.95 | 2.74 | 4.36 | 5.12 | 5.57 | 5.51 | Upgrade |
Book Value Per Share | 3.63 | 3.81 | 4.07 | 4.28 | 4.44 | 4.44 | Upgrade |
Tangible Book Value | 5.85 | 6.16 | 6.71 | 7.17 | 7.53 | 7.52 | Upgrade |
Tangible Book Value Per Share | 2.65 | 2.79 | 3.03 | 3.23 | 3.39 | 3.38 | Upgrade |
Land | - | 1.14 | 1.14 | 1.14 | 1.14 | 1.14 | Upgrade |
Buildings | - | 4.04 | 3.91 | 3.81 | 3.52 | 3.52 | Upgrade |
Machinery | 0.27 | 0.27 | 0.27 | 0.25 | 0.25 | 0.23 | Upgrade |
Leasehold Improvements | 0.19 | - | - | - | - | - | Upgrade |
Order Backlog | - | 3.65 | 6.3 | 5.81 | 6.13 | - | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.